نتایج جستجو برای: شرکت novartis
تعداد نتایج: 53699 فیلتر نتایج به سال:
Disclosure of potential conflict of interest: L. Cox is a consultant for Genentech/Novartis, Hollister-Stier, and Stallergenes; is a speaker for Novartis; has received research support from Stallergenes; is on the Board of Directors for the American Board of Allergy and Immunology; and is on the US Food and Drug Administration (FDA)’s Allergenic Product Advisory Committee. H. Nelson is a consul...
We describe a novel collaboration between academia and industry, an in-house data science artificial intelligence challenge held by Novartis to develop machine learning models for predicting drug development outcomes, building upon research at MIT using from Informa® as the starting point. Over 50 cross-functional teams 25 offices around world participated in challenge. The domain expertise of ...
Affi liations: From the Section of Pulmonary and Critical Care Medicine, Asthma Clinical Research Center (Dr Hanania), Baylor College of Medicine; Division of Pulmonary and Critical Care Medicine (Dr Celli), Brigham and Women’s Hospital, Harvard University; Division of Pulmonary Disease and Critical Care Medicine (Dr Donohue), University of North Carolina at Chapel Hill; and Clinical Research, ...
250 words, Text: 3718 words # of figures: 4, # of tables: 2 # of references: 25 Corresponding Author: Anas Younes, MD. Lymphoma Service, Memorial Sloan-Kettering Cancer Center 1275 York Avenue, Box 330, New York, NY 10065 email: [email protected], Phone 212-639-5059, Fax: 646-422-2291 Disclosure of Potential Conflict of Interest Y.O. received research funding from Novartis. L.Fayad. received re...
Affi liations: From the Section of Pulmonary and Critical Care Medicine, Asthma Clinical Research Center (Dr Hanania), Baylor College of Medicine; Division of Pulmonary and Critical Care Medicine (Dr Celli), Brigham and Women’s Hospital, Harvard University; Division of Pulmonary Disease and Critical Care Medicine (Dr Donohue), University of North Carolina at Chapel Hill; and Clinical Research, ...
Purpose To better understand the reality of living with diseases and conditions that its drugs therapies are developed to treat, Novartis leadership determined a need for more meaningful insights into patients’ lives. They sought develop systematic, creative methodology – informed by psychology insightful rather than analytical thinking properly integrate deploy research commissioned day-to-day...
نمودار تعداد نتایج جستجو در هر سال
با کلیک روی نمودار نتایج را به سال انتشار فیلتر کنید